Neelam Mukherjee相关文献与解析，生知库 | 链接生命科学的每一步

Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancer

牛分枝杆菌 BCG 的选择性脱脂保留了对非肌层侵袭性膀胱癌的抗肿瘤功效

Niannian Ji #, Meijun Long #, Andreu Garcia-Vilanova, Russell Ault, Juan I Moliva, Kizil A Yusoof, Neelam Mukherjee, Tyler J Curiel, Hong Dixon, Jordi B Torrelles, Robert S Svatek

肿瘤

膀胱癌

发表日期：2023

文献求助收藏

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

CD122 靶向白细胞介素 2 在膀胱癌中的治疗机制与 αPD-L1 不同，包括组织选择性 γδ T 细胞活化

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.3

doi:10.1136/jitc-2020-002051

Ryan Michael Reyes, Yilun Deng, Deyi Zhang, Niannian Ji, Neelam Mukherjee, Karen Wheeler, Harshita B Gupta, Alvaro S Padron, Aravind Kancharla, Chenghao Zhang, Myrna Garcia, Anand V R Kornepati, Onur Boyman, Jose R Conejo-Garcia, Robert S Svatek, Tyler J Curiel

CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation

CD122 靶向白细胞介素 2 和 αPD-L1 通过不同的机制治疗膀胱癌和黑色素瘤，包括 CD122 驱动的自然杀伤细胞成熟

期刊:Oncoimmunology

影响因子:

doi:10.1080/2162402X.2021.2006529

Ryan M Reyes, Chenghao Zhang, Yilun Deng, Niannian Ji, Neelam Mukherjee, Alvaro S Padron, Curtis A Clark, Robert S Svatek, Tyler J Curiel

Dermal Lymphatic Invasion: A Rare Feature in Benign Intradermal Nevus

真皮淋巴管侵犯：良性皮内痣的一种罕见特征

期刊:International Journal of Applied and Basic Medical Research

影响因子:0.8

doi:10.4103/ijabmr.IJABMR_397_17

Sood, Neelam; Mukherjee, Moushmi

发表日期：2018

文献求助收藏

SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer

SETD6 调节尿路上皮细胞存活中的 NF-κB 信号：对膀胱癌的影响

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.14750

Neelam Mukherjee, Eduardo Cardenas, Roble Bedolla, Rita Ghosh

Low-Dose Eribulin Promotes NK Cell-Mediated Therapeutic Efficacy in Bladder Cancer

低剂量 Eribulin 促进 NK 细胞介导的膀胱癌治疗效果

Perioperative Immune Checkpoint Blockade for Muscle-Invasive and Metastatic Bladder Cancer

肌肉浸润性和转移性膀胱癌的围手术期免疫检查点阻断

Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancer

牛分枝杆菌 BCG 的选择性脱脂保留了对非肌层侵袭性膀胱癌的抗肿瘤功效

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

CD122 靶向白细胞介素 2 在膀胱癌中的治疗机制与 αPD-L1 不同，包括组织选择性 γδ T 细胞活化

CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation

CD122 靶向白细胞介素 2 和 αPD-L1 通过不同的机制治疗膀胱癌和黑色素瘤，包括 CD122 驱动的自然杀伤细胞成熟

Dermal Lymphatic Invasion: A Rare Feature in Benign Intradermal Nevus

真皮淋巴管侵犯：良性皮内痣的一种罕见特征

SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer

SETD6 调节尿路上皮细胞存活中的 NF-κB 信号：对膀胱癌的影响